Raymond de Vre, a director at Codexis, has executed a sale of shares amounting to $6,173. This transaction reflects the ongoing activities of company insiders in managing their stock holdings. The details of the sale have been disclosed in accordance with regulatory requirements for insider trading. Codexis continues to operate in the biotechnology sector, focusing on enzyme and protein engineering.
Related Articles
Don't miss out on breaking stories and in-depth articles.